Found: 10
Select item for more details and to access through your institution.
Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis.
- Published in:
- Human Genetics, 2004, v. 115, n. 3, p. 200, doi. 10.1007/s00439-004-1151-5
- By:
- Publication type:
- Article
Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 162, n. 1, p. 225, doi. 10.1007/s11060-023-04285-8
- By:
- Publication type:
- Article
Electroencephalographic (EEG) density spectral array monitoring in children during sevoflurane anaesthesia: a prospective observational study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Intelligence quotient scores at the age of 6 years in children anaesthetised before the age of 5 years.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Impact of fruit orientation and pelleting material on water uptake and germination performance in artificial substrate for sugar beet.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0232875
- By:
- Publication type:
- Article
Quantification of seed-soil contact of sugar beet (Beta vulgaris) using X-ray Computed Tomography.
- Published in:
- Plant Methods, 2017, v. 13, p. 1, doi. 10.1186/s13007-017-0220-4
- By:
- Publication type:
- Article
Soil seedbed engineering and its impact on germination and establishment in sugar beet (Beta vulgaris L.) as affected by seed–soil contact.
- Published in:
- Seed Science Research, 2018, v. 28, n. 3, p. 236, doi. 10.1017/S0960258518000168
- By:
- Publication type:
- Article
P04.07 The molecular evolution of oligodendrogliomas.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii20, doi. 10.1093/neuonc/noab180.064
- By:
- Publication type:
- Article
P11.08 Defining EGFR amplification status for clinical trial inclusion.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii43, doi. 10.1093/neuonc/noz126.154
- By:
- Publication type:
- Article
P01.066 Patients with EGFR amplification but without EGFRvIII expression have improved benefit compared to those with EGFRvIII expression in samples of the INTELLANCE 2/EORTC 1410 randomized phase II trial.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii244, doi. 10.1093/neuonc/noy139.108
- By:
- Publication type:
- Article